Weight Changes and Treatment Expectations Weight loss is a common reason people ask about semaglutide generic products, but expectations should match the specific medicine and dose
Excess weight can cause insulin resistance, where the bodys cells become less responsive to insulin, leading to elevated blood sugar levels
Weight loss drugs continue to play out in the global market, with forecasts estimated at a value of US$200 billion by 2030
Diakogiannaki E, Pais R, Tolhurst G, Parker HE, Horscroft J, Rauscher B, et al
GLP-1 Agonists as a Complementary Tool : In contrast, while GLP-1 agonists can aid in reducing body weight and improving health markers, they are less likely to produce the transformative weight loss that is often necessary for significant disease resolution in morbidly obese patients